A living hydrogel has been developed with metabolically and optogenetically engineered E. coli encapsulated within an agarose-based hydrogel matrix to produce and release deoxyviolacein in response to blue light irradiation. Localized, tunable and prolonged drug release have been demonstrated.
Optoregulated Drug Release from an Engineered Living Hydrogel
14 September 2018, Version 1
This content is a preprint and has not undergone peer review at the time of posting.